Sarah Bathers

aTTom: Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years in 6,953 women with early breast cancer.

Richard Gray, Daniel Rea, Kelly Handley et al. · Journal of Clinical Oncology · 2013 · 450 citations

Medicine, Oncology, Breast Oncology +11

Slow N-acetylation genotype is a susceptibility factor in occupational and smoking related bladder cancer

Angela Risch, D. Michael A. Wallace, Sarah Bathers et al. · Human Molecular Genetics · 1995 · 228 citations

Medicine, Genetics, Oncology +10

Epirubicin and Cyclophosphamide, Methotrexate, and Fluorouracil as Adjuvant Therapy for Early Breast Cancer

Christopher Poole, Helena Earl, Louise Hiller et al. · New England Journal of Medicine · 2006 · 189 citations · Full text

Medicine, Oncology, Pharmacology +16

Delay and survival in bladder cancer

D. Michael A. Wallace, Richard T. Bryan, Janet Dunn et al. · British Journal of Urology · 2002 · 161 citations

Medicine, Oncology, Urology +14

aTTom: Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years in 6,953 women with early breast cancer.

Richard Gray, Daniel Rea, Kelly Handley et al. · Journal of Clinical Oncology · 2013 · 100 citations

Medicine, Oncology, Breast Oncology +11